BM
BMY
Market ClosedBristol-Myers Squibb Company
US
32.50K employees
CEO: Christopher Boerner
Founded: 1972
$66.82
+$0.00(+NaN%)
Market Cap
136.49B
Beta
0.23
52W Range
N/A
Dividend Yield
3.76%
Forecasting Analysis
AI-powered predictions and statistical risk modeling for short-term price movements
AI Insight:
Bristol-Myers Squibb's AI short-term forecast is trending modestly lower, indicating near-term downside risk. Analyst consensus projects a broader downside over 12 months, with strong coverage but wide disagreement among estimates. This disparity signals elevated uncertainty and potential volatility in the stock’s outlook.
Current Price
N/A
Last closing price
Price Prediction
Machine learning prediction based on historical price patterns
Period:
Analyst Price Target for BMY
Loading analyst price targets...
Wall Street Forecasts
Revenue Forecast
Past Growth
N/A
Based on Historical CAGR
Forward Growth
N/A
Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
Revenue Analysis
Comparison of Actual and Estimated Revenues
Loading chart data...
Revenue growth steady at 0.0%.
Operating Profitability Forecast
Past Growth
N/A
EBITDA Historical CAGR
Forward Growth
N/A
EBITDA Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
EBITDA Analysis
Comparison of Actual and Estimated EBITDA
Loading chart data...
EBITDA maintaining 0.0% trajectory.
Earnings Per Share Forecast
Past Growth
N/A
EPS Historical CAGR
Forward Growth
N/A
EPS Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
EPS Analysis
Comparison of Actual and Estimated Earnings Per Share
Loading chart data...
EPS growth stable around 0.0%.
Explore BMY
BMY in the Healthcare
Large Cap